Product Overview
Dragon Pharma Methyl-1-Test is methyl-1-testosterone in 10 mg tablets, 100 per pack, also written as M1T or methyldihydroboldenone. Structurally it is a 17-alpha-methylated derivative of 1-testosterone, and that single methyl group does two things at once: it lets the tablet pass first-pass liver metabolism intact, and it also puts a heavy load on the liver. The compound never reached the medical market, and the reference record includes a 2006 Health Canada warning about liver damage, reduced fertility and artery stiffening in supplements containing M1T.
The profile is fast and dry. M1T does not aromatise, so it produces no estrogen and no classic water retention, and the scale weight it adds is tissue and glycogen rather than subcutaneous fluid. Speed of onset is one of the highest among oral anabolics, which is why the sensible block is measured in weeks rather than in months: hepatic enzymes are expected to rise, and the practical limits are set by blood work rather than by ambition. It also suppresses the testosterone axis strongly even across a 2-3 week run, so a recovery plan belongs in the plan from day one.
Because it is a 17-alpha-alkylated oral, M1T must not be stacked with another oral of the same type such as Superdrol, Anadrol or Halotestin; the hepatic loads add together instead of sitting side by side. In practice it serves either as a very short dry-mass block ahead of a long injectable base, with Enantat 250 or its Cypionat 250 counterpart, or it is dropped altogether in favour of a milder oral. This is a specialist product, not a first cycle.
Dosage Protocol
The reference ranges for M1T are deliberately low, and the notes matter as much as the numbers.
| Beginner | 5-10 mg daily across 2-3 weeks, split into two intakes; start at the bottom of the range |
| Intermediate | 10-15 mg a day for 3-4 weeks with liver support and enzyme monitoring |
| Advanced | Up to 20 mg a day and not beyond; doses above 20 mg a day are associated with reports of liver complaints, and the block does not exceed 4 weeks |
| Female | No confirmed data: virilization is not a confirmed safe protocol, so this product is not positioned for female use |
| Administration | Oral, divided into two doses a day; never stacked with another hepatotoxic oral such as Superdrol, Anadrol or Halotestin |
Suggested Protocols
M1T is a short block, and the point of every pattern below is to keep it short while an injectable base does the heavy lifting.
What to Expect
- Fast onset. Strength and body weight move noticeably within the first week, faster than with almost any other oral.
- Dry look. Because the compound does not aromatise, there is no classic water retention and the gain reads as dense rather than puffy.
- Short window. The same speed that makes it work makes long blocks pointless and dangerous, so 2-4 weeks is the whole story.
- Strong suppression. The axis is suppressed hard even on a 2-3 week block, so recovery therapy is required rather than optional.
- Hepatic enzymes rise. Expect transaminases to climb and plan tests around the block instead of guessing.
- Lethargy and low libido. Feeling flat and uninterested is a common on-cycle complaint and is tied to the suppressed axis.
- Regulatory warning. Health Canada warned in 2006 about liver damage, reduced fertility and arterial stiffening with M1T-containing products, which is the context behind the short blocks.
Side Effects and Management
The ledger for this product is dominated by the liver and by axis suppression, and both escalate quickly with dose and duration.
Post-Cycle Therapy
Recovery starts the day after the last tablet, because the oral clears quickly and the axis does not.
